Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9/15/23 16:51 | 9/13/23 | INAB | Health | BioPrd | Biological Products, (No Diag | Graff Jeremy R. | NY | D | 1 | P | 2 | 0.9500 | 0 | 3 | 3 | D | ||||||||||||||||
8/28/23 16:43 | 8/25/23 | INAB | Health | BioPrd | Biological Products, (No Diag | McCall Patrick | NY | O | CFO | 1 | P | 1 | 1.03 | 0 | 1 | 19 | 6 | D | ||||||||||||||
8/28/23 16:42 | 8/24/23 | INAB | Health | BioPrd | Biological Products, (No Diag | Ho William Tai-Wei | NY | DOT | P,CEO | 1 | P | 25 | 1.05 | 0 | 24 | 1 | 2,595 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |